AstraZeneca and Merck, known as MSD outside the United States and Canada, have announced that LYNPARZA has been approved...
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, announces that it has successfu...
Eisai Co., Ltd. has announced that it has completed construction of the 5th manufacturing building at the Kawashima Indu...
NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...
WuXi Biologics, a global company with leading open-access biologics technology platforms, and Bayer, have announced an a...
Hyundai Bioscience has announced that CNPharm, its major shareholding biotech company, has succeeded in developing 'Poly...
Alterity Therapeutics has announced it has been granted a licence by UniQuest, the commercialisation company of The ...
Takeda Pharmaceutical Company, headquartered in Japan, has announced that it has entered into an agreement to divest a p...
Lumosa, based in Taiwan, has announced the market approval of LT1001 (Naldebain®), an extended-release analgesic i...
Alvotech and Japanese pharmaceutical company Fuji Pharma have announced that they have agreed on an extension on their e...
The Japanese immunology market is highly competitive with many innovator products available for rheumatoid arthritis (RA...
British multinational AstraZeneca and US based Alexion Pharmaceuticals, Inc. have entered into a definitive agreement fo...
PharmaBlock Sciences (Nanjing), Inc., a leading innovative chemistry product and service provider throughout the pharmac...
Logistics4Pharma, a German pharmaceutical logistics and cold chain specialist, recently completed a successful inspectio...
The pharmaceutical sector is a strong pillar in Singapore’s economy, contributing to around 3% of Singapore’...
Singapore’s supportive ecosystem of government policies and processes, an excellent track record of quality and re...
Vetter, a global leading Contract Development and Manufacturing Organization (CDMO) is continuously investing in climate...
Pharmaceutical companies are poised for significant growth within the Asia Pacific region, with projections estimated as...
Japanese firm Takeda Pharmaceutical Company Limited has announced the completion of its previously-announced sale of a p...
Thousands of Australians with debilitating back and joint pain will have access to a life changing treatment option thro...
Japan's Takeda Pharmaceutical Company Limited has announced a share exchange where Takeda will be the wholly-owning pare...
OnRobot has opened registration for ‘OnRobot Expo’ – a global, interactive digital robotics event focu...
Switzerland based Bioversys has recently reached a major milestone by entering clinical development with the start of Ph...
Following the release of Chemistry42 to a select group of key experts in the pharmaceutical industry in Q3 2020, In...
